Cargando…
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia
A number of new cholesterol-lowering drugs have been recently developed and approved, enriching the pharmacological armamentarium beyond and above statins. Ezetimibe, available since two decades, and bempedoic acid, a new drug inhibiting the same biosynthetic pathway targeted by statins but at an ea...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915986/ https://www.ncbi.nlm.nih.gov/pubmed/34980867 http://dx.doi.org/10.1097/MED.0000000000000706 |